Key points are not available for this paper at this time.
Background To evaluate the impact of having first-degree relatives (FDR) with bladder cancer (BC) among non-muscle invasive bladder cancer (NMIBC) patients treated with Bacillus Calmette – Guérin (BCG) on their oncological outcomes.
Chakra et al. (Sun,) studied this question.